comparemela.com

Latest Breaking News On - Biologics advisory committee - Page 1 : comparemela.com

Transcripts For CSPAN Trump V Vance Oral Argument 20240712

The court heard arguments from the president s attorney in the manhattan District Attorneys office. The central issue surrounds the subpoena for the president s finances as part of an investigation into alleged misconduct i the president s company, the Trump Organization. This is the second time this case has appeared before the court. The first was in october of 2019. It ended up before the u. S. Supreme court in may of 2020 and the justices ultimately ruled in favor of the das office and subpoena. But also remanded the case back to the lower courts for additional consideration. This is one hour and 20 minutes. 20 minutes. We will hear from trump the vance. The way we will proceed is that each side will have on interrupted arguments. Then there will be questioning in order of that with judge lavalle first then me and then judge. You will begin and you have reserved three minutes for a rebuttal. Thank you your honor and good morning. Good morning. And may it please the court, on remand

Transcripts For CSPAN3 Hearing On Flu Season Preparedness 20151125

And wanted to make sure when the case was over not only was edie still alive but healthy enough to enjoy it so that was very much weighing on me. I said forget it. No extension. Shes interviewed by zoe tillman. Watch book tv all weekend every weekend on cspan 2. And now a house subcommittee looks at u. S. Public Health Preparations for the flu season and other Infectious Diseases, witnesses testified about preparations under way as well as lessons learned. From earlier this month. This is about an hour 20 minutes. Good morning. We have this subcommittee hearing from oversight and investigation. Earlier this year in february this subcommittee held a hearing on last years flu vaccine mismatch. This mismatch to the predominant flu virus resulted in more deaths and hospitalizations because of the vaccines lowerthanusual effectiveness. Today we return to that issue to discuss what our Public Health agencies have learned in the intervening months. I want to thank the Ranking Member for her c

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.